Hyderabad, undefined

Ajay Kumar Bachupally

This inventor holds 1 USPTO granted patent. Top assignees: Etico Lifesciences Private Limited, Hyloris Developments Sa. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ajay Kumar Bachupally. Retrieved from https://idiyas.com/inventor/ajay-kumar-bachupally

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ajay Kumar Bachupally: Pharmaceutical Formulation Inventor.

Introduction

Ajay Kumar Bachupally is an inventor based in Hyderabad, India. His patent work concerns a stable, injectable liquid formulation of pantoprazole, a medicine used to reduce stomach acid.

Latest Patents

Bachupally is associated with 1 patent: “Liquid, Storage Stable, Directly Injectable, Pantoprazole Formulations, Their Uses and Manufacturing.” The invention describes a concentrated, storage-stable liquid composition containing pantoprazole or a pharmaceutically acceptable salt. It covers ready-to-use solutions and ready-to-dilute formulations intended for dilution with an infusion solution, along with their preparation, packaging, and use. The formulation is designed for storage at controlled room temperature.

Career Highlights

Bachupally has been associated with Etico Lifesciences Private Limited and Hyloris Developments SA. His patent reflects work on pharmaceutical formulation and the development of injectable medicines designed for practical storage and administration.

Collaborations

His listed coworkers include Soumya Kondaveeti and Shanmukha Srinivas Mule. Their names are associated with the collaborative work connected to the pantoprazole formulation patent.

Conclusion

Ajay Kumar Bachupally’s patent focuses on making pantoprazole available as a storage-stable liquid formulation for direct injection or dilution, highlighting his contribution to pharmaceutical formulation innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…